Koj nyob ntawm no: Tsev »
AOMA BLOG »
Xov xwm kev lag luam »
Yuav Ua Li Cas Hloov Los Ntawm Saxenda rau Wegovy: Lub Sijhawm, Kev Siv Tshuaj thiab Dab Tsi Yuav Tau Txais
Yuav Ua Li Cas Hloov Los Ntawm Saxenda mus rau Wegovy: Lub Sijhawm, Kev Siv Tshuaj thiab Yuav Ua Li Cas
Ntau txhiab tus neeg mob uas tau pib nyob rau txhua hnub Saxenda tam sim no nug tib lo lus nug: nws puas yog lub sijhawm txav mus rau Wegovy ib zaug ib lub lim tiam, thiab yuav ua li cas hloov qhov kev nyab xeeb? Ob cov tshuaj yog GLP-1 receptor agonists ua los ntawm Novo Nordisk, tab sis lawv siv cov molecules sib txawv (liraglutide vs semaglutide), sib txawv dosing rhythms thiab sib txawv titration sij hawm. Tau txais txoj cai hloov pauv tiv thaiv kev zam, ua kom poob phaus thiab zam kev ua yuam kev xws li kev sib tshooj ntawm ob cov tshuaj.
Yog tias koj xav tau lub taub hau-rau-lub taub hau saib cov tshuaj twg haum rau tus neeg mob, saib peb phau ntawv qhia ua ntej, Sib piv Wegovy thiab Saxenda: Yam tshuaj poob phaus zoo rau koj . Kab lus no tsom mus rau qee yam sib txawv: cov txheej txheem ua tau zoo ntawm kev hloov ntawm Saxenda mus rau Wegovy, suav nrog lub sijhawm, pib koob tshuaj, titration thiab cov neeg mob thiab cov chaw kho mob yuav tsum xav li cas hauv thawj lub hlis.
Vim li cas cov neeg mob hloov ntawm Saxenda mus rau Wegovy
Qhov nruab nrab hnyav dua. Hauv KAUJ RUAM 8 randomized sim, cov neeg laus uas tsis muaj ntshav qab zib poob qhov txhais tau tias 15.8% ntawm lub cev qhov hnyav ntawm semaglutide 2.4 mg txhua lub lim tiam piv rau 6.4% ntawm liraglutide 3.0 mg txhua hnub dhau 68 lub lis piam (Rubino li al., JAMA 2022).
Kev txhaj tshuaj tsawg dua. Ib qho kev txhaj tshuaj rau ib lub lim tiam tsis yog xya ua rau kev ua raws li yooj yim rau ntau tus neeg.
Ib lub toj siab ntawm Saxenda. Saxenda daim ntawv qhia qhia kom nres kev kho mob yog tias tus neeg laus tsis tau poob tsawg kawg 4% ntawm qhov hnyav hauv qab tom qab 16 lub lis piam, uas ua rau ntau tus kws kho mob tshuaj xyuas lwm txoj hauv kev.
Kev hloov pauv tsis tas yuav tsum tau ua. US Veterans Affairs conversion kev taw qhia tsis tas yuav hloov tus neeg mob uas ua tau zoo thiab poob phaus ntawm liraglutide. Qhov kev txiav txim siab yuav tsum yog tus kheej ib txwm.
Saxenda vs Wegovy Dosing at a Glance
Raws li cov ntaub ntawv tshaj tawm hauv Tebchaws Meskas:
Saxenda (liraglutide) yog txhaj subcutaneously ib hnub ib zaug . Nws pib ntawm 0.6 mg ib hnub rau ib lub lis piam thiab nce los ntawm 0.6 mg txhua lub lim tiam (1.2 mg, 1.8 mg, 2.4 mg) kom txog rau thaum 3 mg ib hnub txij nkawm koob mus txog rau lub lim tiam 5. Cov koob tshuaj qis dua yog rau titration nkaus xwb.
Wegovy (semaglutide) txhaj tshuaj subcutaneously ib zaug ib lub lim tiam , nyob rau tib hnub txhua lub lim tiam. Lub sij hawm escalation yog:
Lub lis piam 1-4: 0.25 mg
Lub lis piam 5-8: 0.5 mg
Lub lis piam 9–12: 1 mg
Lub lis piam 13–16: 1.7 mg
Lub lim tiam 17 txuas ntxiv mus: kev saib xyuas ntawm 2.4 mg (pom zoo) lossis 1.7 mg
Daim ntawv lo tam sim no hauv Teb Chaws Asmeskas tseem tso cai rau cov neeg laus uas tau zam 2.4 mg rau tsawg kawg 4 lub lis piam kom nce mus rau qhov siab tshaj plaws ntawm 7.2 mg txhua lub lim tiam thaum txo qhov hnyav ntxiv yog tshuaj xyuas. Cov koob tshuaj thiab qhov muaj zog muaj zog sib txawv los ntawm lub teb chaws, yog li nco ntsoov ua raws li daim ntawv lo hauv zos. Rau keeb kwm yav dhau ntawm seb semaglutide ua haujlwm li cas, nyeem Nkag siab Semaglutide Txhaj Tshuaj thiab Nws Siv.
Ob daim ntawv teev npe hais tias cov tshuaj yuav tsum tsis txhob ua ke nrog lwm tus GLP-1 receptor agonist. Ib txoj cai ntawd ua rau tag nrho cov txheej txheem hloov pauv.
Yuav Ua Li Cas Hloov Los Ntawm Saxenda mus rau Wegovy: Kauj Ruam los ntawm Kauj Ruam
Tsis yog Wegovy lossis Saxenda daim ntawv lo tsis muaj cov txheej txheem hloov pauv ntawm Saxenda-rau-Wegovy. Dab tsi hauv qab no qhia txog kev tshaj tawm cov lus qhia kho mob thiab kev coj ua. Tus kws tshuaj ib txwm ua qhov kawg hu.
Cov kws kho mob thawj zaug paub tseeb tias yog vim li cas tus neeg mob xav hloov, txawm tias qhov ua tau zoo, yooj yim, nqi lossis kev mob tshwm sim. Tom qab ntawd lawv rov xyuas cov contraindications. Wegovy yuav tsum tsis txhob siv rau cov neeg mob uas muaj tus kheej lossis tsev neeg keeb kwm ntawm medullary thyroid carcinoma los yog txiv neej 2, thiab cov neeg mob ntshav qab zib hom 2 yuav tsum tau saib xyuas cov piam thaj thaum hloov.
Kauj Ruam 2: Lub Sijhawm - Tsis Xav Tau Kev Ntxuav
Cov lus qhia siv tau tshaj tawm hauv Kev Kho Mob Ntshav Qab Zib (Almandoz, Lingvay thiab Morales, 2020) qhia tias tus neeg mob uas kam rau ib hnub GLP-1 agonist ntawm tag nrho cov koob tshuaj tuaj yeem pib tus neeg sawv cev txhua lub limtiam hnub tom qab noj tshuaj txhua hnub kawg . New Zealand's Christchurch Medicines Information Service (2025) kuj tau hais tias tsis tas yuav tsum muaj lub sijhawm ntxuav. Noj ob yam tshuaj ua ke tsis pom zoo nyob rau hauv ob daim ntawv lo.
Muaj ib qho kev zam. Yog tias qhov hloov pauv tau tshwm sim vim muaj kev mob tshwm sim hauv plab hnyuv, tib txoj kev qhia qhia kom nres Saxenda thiab tos kom txog thaum cov tsos mob daws teeb meem ua ntej pib Wegovy ntawm nws cov koob tshuaj qis tshaj.
Cov neeg mob ntawm 1.8-2.4 mg txhua hnub: 0.25 mg lossis 0.5 mg txhua lub lim tiam.
Cov neeg mob ruaj khov ntawm 3 mg txhua hnub: qee qhov kev pabcuam (VA, CMIS) qhia 0.5 mg txhua lub lim tiam raws li qhov pib tawm ntawm daim ntawv lo.
Pib ntawm 0.25 mg, raws li daim ntawv qhia Wegovy pom zoo, tseem yog qhov kev xaiv zoo tshaj plaws thiab daim ntawv lo sib xyaw.
Kauj Ruam 4: Txhim kho txhua 4 lub lis piam
Los ntawm qhov pib koob tshuaj, Wegovy tau nce txhua 4 lub lis piam mus rau 1.7 mg lossis 2.4 mg. Yog tias koob tshuaj tiv thaiv tsis zoo, daim ntawv lo tso cai rau qhov kev nce ntxiv tom ntej yuav ncua sijhawm li 4 lub lis piam. Ntawm cov koob tshuaj uas tsis tau, daim ntawv lo hais tias yog tias ib koob tshuaj tsis tuaj thiab tom ntej yog ntau tshaj 2 hnub, nws yuav tsum tau noj sai li sai tau. Yog tias ob lossis ntau qhov koob tshuaj sib law liag lawm, yuav tsum tau rov kho dua los ntawm kev txhaj tshuaj qis dua.
Yuav Ua Li Cas Tom Qab Kev Hloov Pauv
Mob plab hnyuv
Kev xeev siab, raws plab, ntuav thiab cem quav yog qhov cuam tshuam loj tshaj plaws ntawm ob qho tshuaj. Hauv KAUJ RUAM 8, cov xwm txheej hauv plab hnyuv tau tshaj tawm los ntawm 84.1% ntawm cov neeg siv semaglutide thiab 82.7% ntawm cov neeg siv liraglutide, feem ntau me me mus rau nruab nrab. Txawm li cas los xij, tsawg tus neeg koom tsis tau txiav semaglutide (13.5%) dua liraglutide (27.6%). Cov zaub mov me me, txwv tsis pub noj thaum puv thiab nyob twj ywm pab cov neeg mob feem ntau los ntawm txhua kauj ruam tshiab.
Qhov hnyav-Poob Trajectory
Vim tias qhov pib koob tshuaj Wegovy tsawg, qee cov neeg mob pom tias muaj kev noj qab haus huv me ntsis hauv thawj lub lis piam tom qab tso tseg 3 mg Saxenda. Qhov no feem ntau settles thaum cov koob tshuaj nce. Hauv KAUJ RUAM 8, 70.9% ntawm cov neeg koom nrog semaglutide ua tiav tsawg kawg 10% poob phaus, piv nrog 25.6% ntawm liraglutide. Cov txiaj ntsig tseem nyob ntawm kev noj zaub mov, kev ua si thiab tus kheej biology.
Tsis quav ntsej cov tshuaj ntshav qab zib. Cov neeg mob ntawm cov tshuaj insulin lossis sulfonylureas yuav tsum tau hloov kho koob tshuaj kom tsis txhob muaj ntshav qab zib.
Siv cov khoom tsis raug cai 'semaglutide'. Cov neeg mob yuav tsum tau siv cov khoom tso cai, tshuaj los ntawm cov khw muag tshuaj raug cai.
Qhov no txhais li cas rau Clinics thiab Distributors
Rau cov chaw kho kom zoo nkauj thiab kev noj qab haus huv, qhov nce ntawm kev kho GLP-1 txhua lub lim tiam yog hloov kho cov neeg mob taug kev. Cov neeg mob ntawm kev tswj qhov hnyav feem ntau nrhiav lub cev-contouring, tawv nqaij-zoo thiab ntim-restoring kev kho mob thaum los yog tom qab lawv txoj haujlwm. Peb lub ntsiab lus ntawm Sab saum toj Tsis-Kev phais Lub Cev Contouring thiab Kev Tswj Qhov hnyav rau 2026 daim duab qhia chaw qhov kev xav tau txav mus.
Cov tuam txhab lag luam thiab cov neeg muag khoom tsim kom muaj kev tswj hwm qhov hnyav yuav tsum ua ke cov tshuaj noj tsuas yog GLP-1 kev saib xyuas, uas nyob hauv kev saib xyuas kev kho mob, nrog rau cov khoom siv ua raws li cov khoom siv ntxiv, collagen stimulators, mesotherapy thiab lub cev-contouring injectables. Txhawm rau kom nkag siab tias kev sib koom tes ntiag tug-label ua haujlwm li cas, nyeem Tshawb nrhiav OEM Poob Poob Txhaj Tshuaj: Ib Lub Sijhawm Zoo rau Kev Noj Qab Haus Huv thiab Kev Noj Qab Haus Huv Kev Lag Luam . AOMA txhawb kev koom tes nrog GMP-raws li kev tsim khoom, cov ntaub ntawv tswj hwm thiab kev cai tsim khoom.
FAQ
Kuv tuaj yeem pib Wegovy hnub tom qab kuv txhaj tshuaj Saxenda kawg?
Feem ntau, yog. Tshaj tawm cov lus qhia hais tias tsis tas yuav tsum tau ntxuav tawm, thiab tus neeg sawv cev txhua lub lim tiam tuaj yeem pib hnub tom qab koob tshuaj txhua hnub kawg. Yog tias koj hloov pauv vim muaj kev phiv, koj tus kws kho mob yuav hais kom koj tos kom txog thaum cov tsos mob kho.
Kuv yuav tsum noj tshuaj Wegovy dab tsi tom qab Saxenda 3 mg?
Daim ntawv qhia Wegovy pib txhua tus ntawm 0.25 mg txhua lub lis piam. Qee qhov kev pabcuam kho mob xav txog 0.5 mg off-label rau cov neeg mob ruaj khov ntawm Saxenda 3 mg. Koj tus kws kho mob txiav txim siab raws li koj lub siab ntev.
Kuv puas tuaj yeem nqa Saxenda thiab Wegovy ua ke?
Tsis yog. Ob daim ntawv teev npe hais tias kev sib txuas nrog lwm tus GLP-1 receptor agonist tsis pom zoo.
Nws yuav siv sijhawm ntev npaum li cas kom ncav cuag qhov koob tshuaj Wegovy?
Los ntawm 0.25 mg, nce mus txog 2.4 mg yuav siv sijhawm 16 lub lis piam, nrog kev saib xyuas txij li lub lim tiam 17. Pib ntawm 0.5 mg ua qhov no los ntawm 4 lub lis piam.
Puas yog Wegovy zoo dua Saxenda?
Hauv KAUJ RUAM 8 lub taub hau-rau-lub taub hau sim, semaglutide 2.4 mg ua rau qhov nruab nrab 15.8% poob phaus piv rau 6.4% nrog liraglutide 3.0 mg ntawm 68 lub lis piam. Cov txiaj ntsig ntawm tus kheej sib txawv.
Medical Disclaimer
Kab lus no yog rau kev kawm dav dav thiab rau kev kho mob thiab cov kws tshaj lij kev lag luam. Nws tsis yog lus qhia kho mob. Saxenda thiab Wegovy yog cov tshuaj tsuas yog tshuaj. Txhua qhov kev hloov pauv hauv kev kho mob, suav nrog lub sijhawm thiab kev noj tshuaj, yuav tsum tau txiav txim siab los ntawm tus kws kho mob muaj ntawv tso cai raws li cov ntaub ntawv sau tshuaj hauv zos. AOMA tsis tsim lossis muag Saxenda lossis Wegovy, uas yog cov cim lag luam ntawm Novo Nordisk A/S.
Cov ntaub ntawv
Rubino DM, Greenway FL, Khalid U, thiab al. Cov txiaj ntsig ntawm txhua lub limtiam subcutaneous semaglutide vs niaj hnub liraglutide ntawm lub cev qhov hnyav hauv cov neeg laus uas rog dhau lossis rog tsis muaj ntshav qab zib: KAUJ RUAM 8 randomized soj ntsuam. JAMA . 2022; 327(2): 138-150. PIB: 35015037.
Almandoz JP, Lingvay I, Morales J, et al. Hloov ntawm glucagon-zoo li peptide-1 receptor agonists: cov lus qhia thiab kev coj ua. Clin Diabetes . 2020; 38(4):390-402. PIB: 33132510.
WEGOVY (semaglutide) txhaj / ntsiav tshuaj, US Prescribing Information, Novo Nordisk (DailyMed, hloov tshiab Lub Rau Hli 2026).
SAXENDA (liraglutide) txhaj, US Prescribing Information, Novo Nordisk (DailyMed / FDA, 2026).
US Department of Veterans Affairs. Semaglutide (WEGOVY) subcutaneous txhaj tshuaj hloov pauv kev taw qhia rau kev tswj qhov hnyav, Lub Ob Hlis 2023.
Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) yog ib tug kws phais neeg kho hniav uas muaj ntawv pov thawj hauv New York City nrog ntau tshaj 9 xyoo ntawm kev paub tshwj xeeb hauv hyaluronic acid fillers, kho pob txuv caws pliav, thiab ua kom lub ntsej muag me me. Nws tau txais kev lees paub tshwj xeeb rau nws cov kws tshaj lij hauv kev txhaj tshuaj zoo tshaj plaws uas ua kom cov pob txuv ua kom zoo dua qub, txhawb kev kho ntawm daim tawv nqaij, thiab rov ua kom smoothness los ntawm cov phiaj xwm kho tawv nqaij thiab cov txheej txheem ntawm daim tawv nqaij.
